Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 344

1.

G protein-coupled receptors as targets for anti-diabetic therapeutics.

Oh DY, Olefsky JM.

Nat Rev Drug Discov. 2016 Jan 29. doi: 10.1038/nrd.2015.4. [Epub ahead of print]

PMID:
26822831
2.

The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.

Ock CY, Nam AR, Bang JH, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY.

Am J Cancer Res. 2015 Oct 15;5(11):3376-88. eCollection 2015.

3.

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.

Kim MJ, Han SW, Lee DW, Cha Y, Lee KH, Kim TY, Oh DY, Kim SH, Im SA, Bang YJ, Kim TY.

Cancer Res Treat. 2016 Jan 14. doi: 10.4143/crt.2015.296. [Epub ahead of print]

4.

Relationship between Single Nucleotide Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Gene and Fatty Acid Composition in Korean Native Cattle.

Lee JY, Ha JJ, Park YS, Yi JK, Lee S, Mun S, Han K, Kim JJ, Kim HJ, Oh DY.

Asian-Australas J Anim Sci. 2016 Feb;29(2):184-94. doi: 10.5713/ajas.15.0502.

5.

More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity.

Choi Y, Oh DY, Park H, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.

PLoS One. 2016 Jan 4;11(1):e0145692. doi: 10.1371/journal.pone.0145692. eCollection 2016.

6.

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME; RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group.

Lancet. 2015 Dec 15. pii: S0140-6736(15)00817-X. doi: 10.1016/S0140-6736(15)00817-X. [Epub ahead of print]

PMID:
26703889
7.

Solution-Processable Glass LiI-Li4 SnS4 Superionic Conductors for All-Solid-State Li-Ion Batteries.

Park KH, Oh DY, Choi YE, Nam YJ, Han L, Kim JY, Xin H, Lin F, Oh SM, Jung YS.

Adv Mater. 2015 Dec 22. doi: 10.1002/adma.201505008. [Epub ahead of print]

PMID:
26690558
8.

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.

Ock CY, Nam AR, Bang JH, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY.

Gastric Cancer. 2015 Dec 17. [Epub ahead of print]

PMID:
26681196
9.

Pertuzumab in gastrointestinal cancer.

Oh DY, Bang YJ.

Expert Opin Biol Ther. 2015 Dec 23:1-11. [Epub ahead of print]

PMID:
26619359
10.

A Rare Case of Ecthyma Gangrenosum Caused by Proteus vulgaris and Candida albicans in a Patient with Castleman Disease.

Lee YJ, Jung IO, Oh DY.

Arch Plast Surg. 2015 Nov;42(6):805-7. doi: 10.5999/aps.2015.42.6.805. Epub 2015 Nov 16. No abstract available.

11.

Giant Fibroadenoma in the Axilla: A Common Entity of Uncommon Size in a Rare Location.

Seo BF, Park SW, Oh DY.

Arch Plast Surg. 2015 Nov;42(6):793-5. doi: 10.5999/aps.2015.42.6.793. Epub 2015 Nov 16. No abstract available.

12.

Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.

Lee DH, Kim SH, Im SA, Oh DY, Kim TY, Han JK.

Eur Radiol. 2015 Nov 28. [Epub ahead of print]

PMID:
26615555
13.

Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?

Lee KG, Lee HJ, Oh SY, Yang JY, Ahn HS, Suh YS, Kong SH, Kim TY, Oh DY, Im SA, Lee KU, Kim WH, Bang YJ, Yang HK.

Ann Surg Oncol. 2015 Nov 23. [Epub ahead of print]

PMID:
26597366
14.

Salvaging the Exposed Cochlear Implant.

Seo BF, Park SW, Han HH, Moon SH, Oh DY, Rhie JW.

J Craniofac Surg. 2015 Nov;26(8):e749-52. doi: 10.1097/SCS.0000000000002259.

PMID:
26594996
15.

Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.

Oh DY, Lee KW, Cho JY, Kang WK, Im SA, Kim JW, Bang YJ.

Gastric Cancer. 2015 Nov 18. [Epub ahead of print]

PMID:
26581547
16.

Genome-wide Association Study to Identify Quantitative Trait Loci for Meat and Carcass Quality Traits in Berkshire.

Iqbal A, Kim YS, Kang JM, Lee YM, Rai R, Jung JH, Oh DY, Nam KC, Lee HK, Kim JJ.

Asian-Australas J Anim Sci. 2015 Nov;28(11):1537-44. doi: 10.5713/ajas.15.0752.

17.

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

Kim H, Youk J, Yang Y, Kim TY, Min A, Ham HS, Cho S, Lee KH, Keam B, Han SW, Oh DY, Ryu HS, Han W, Park IA, Kim TY, Noh DY, Im SA.

J Cancer Res Clin Oncol. 2015 Nov 18. [Epub ahead of print]

PMID:
26577828
18.

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.

Choi Y, Oh DY, Kim K, Chie EK, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Ha SW, Bang YJ.

Cancer Res Treat. 2015 Oct 16. doi: 10.4143/crt.2015.226. [Epub ahead of print]

19.

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma.

Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ.

BMC Cancer. 2015 Oct 16;15:721. doi: 10.1186/s12885-015-1737-4.

20.

Capecitabine for the treatment of gastric cancer.

Kim TY, Oh DY, Bang YJ.

Expert Rev Gastroenterol Hepatol. 2015;9(12):1471-81. doi: 10.1586/17474124.2015.1096774. Epub 2015 Oct 15.

PMID:
26470733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk